Infusion Pump Market Size, Share & Industry Analysis, By Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management, and Others), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and Regional Forecast, 2026-2034

The global infusion pump market size was valued at USD 12.78 billion in 2025. The market is projected to grow from USD 13.72 billion in 2026 to USD 24.49 billion by 2034, exhibiting a CAGR of 7.51% during the forecast period. North America dominated the infusion pump market with a market share of 38.26% in 2025.

The market is gaining significant traction after introduction of insulin pump by leading market players such as Medtronic, Insulet Corporation etc. The market is projected to expand at considerable growth rate owing to the key factors such as growing prevalence of chronic diseases, advancements in drug delivery technologies, and increasing adoption of these techniques in the emerging regions. This pump is a medical device used to deliver fluids such as nutrients and medicines to the patient in a controlled amount. These are designed based on the specialized functions such as enteral feeding pumps to deliver nutrients, insulin pumps to deliver insulin, and patient controlled analgesia (PCA) pumps for delivery of pain medications. Various routes utilized for fluid delivery by these pumps include intravenous, subcutaneous, and arterial. The practice of these pumps has been encouraged over the manually driven flow control method to provide accurate and exact delivery of the fluid and achieve therapeutic efficacy.

Due to the impact of the COVID-19 pandemic and the uncertainties regarding the duration, the industry had witnessed a strong upward spike in its growth rate. This was majorly due to the increase in the COVID-19 testing during the year 2020. However, due to the unavailability of workers and supply chain disruptions, there was a decline in the production due to the COVID-19 pandemic. For instance, Baxter international has experienced significant and unpredictable reductions and increases in the demand of certain healthcare products during the COVID-19 pandemic. However, new product launches have uplifted the revenue growth in the year 2020. For instance, In January 2020, Medtronic, Ireland has launched Efficio networked with the SynchroMed II intrathecal drug delivery system. The market is projected to witness robust growth prospects over the forecast period of 2024-2032.

Global Infusion Pump Market Snapshot & Highlights

Market Size & Forecast:

• 2025 Market Size: USD 12.78 billion
• 2026 Market Size: USD 13.72 billion
• 2034 Forecast Market Size: USD 24.49 billion
• CAGR: 7.51% from 2026–2034

Market Share:

• North America dominated the infusion pump market with a 38.26% share in 2025, driven by high diagnosis and treatment rates for chronic diseases, strong adoption of ambulatory pumps, and favorable reimbursement policies.
• By type, the insulin pump segment is expected to retain its largest market share owing to the growing number of diabetic patients and continuous technological advancements in self-controlled insulin delivery systems.

Key Country Highlights:

• United States: Increasing preference for home-based infusion therapies supported by advancements in smart infusion systems is driving market growth.
• Europe: Rising healthcare expenditure and focus on chronic disease management are propelling demand for advanced infusion solutions.
• China: Rapidly expanding healthcare infrastructure and growing adoption of automated drug delivery systems are fueling market expansion.
• Japan: Aging population with long-term care needs is accelerating demand for compact, patient-friendly infusion pump technologies.

Infusion Pump Market Trends

Growing Research and Development Activities to Launch Home Infusion Systems and Smart Infusion Pumps

The growing prevalence of chronic diseases coupled with increasing cost of hospital-based infusion therapies has resulted into growing research and development activities to develop home-based infusion products.

• For instance, growing patient population in diabetes, cancer, and neurological disorders has resulted in growing demand for long term care preferably at home care settings.

Moreover, growing geriatric population in need of long-term care therapies is driving the new product developments targeting home-based infusion therapies. The leading players in the market are focusing on site of care management for specialty medicines.

• In August 2020, Ivenix, Inc. has developed a smart infusion pump named as Epic which helps to eliminate infusion-based injuries of patients.

Furthermore, several infusion pump manufacturers are integrating advanced functionalities, such as connectivity to electronic health records, wireless communication, and compatibility with other medical devices. These smart infusion pumps improve the safety, precision, and accessibility of patient data for healthcare professionals. 

• For instance, in August 2022, Baxter received U.S. FDA clearance for its novel Novum IQ syringe infusion pump with Dose IQ Safety Software, depicting the company’s newest developments for infusion therapy.

Download Free sample to learn more about this report.

Infusion Pump Market Growth Factors

Growing Prevalence of Chronic Diseases to Boost Market Growth

Infusion pumps provide important advantages over the manual delivery of fluids like the ability to administer the fluids in a very small dosage and at accurate programmed rates. In many cases like cancer and diabetic conditions, these pumps are used to deliver the medication to maintain drug level in the bloodstream at a steady state.

• According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the pump.
• Moreover, according to the Centers for Disease Control and Prevention (CDC), in 2020, the prevalence of diabetes was estimated to be around 463 million cases worldwide and in the U.S., 34.2 million adults have diabetes which is 10.5% of the total population.

The insulin pumps are increasingly being preferred in the management of type 1 diabetes. These patients necessitate user friendly self-controlled pumps to achieve continuous medication delivery. Together, these factors are surging the infusion pump market growth across all regions.

Growing Demand for Ambulatory Pumps to Propel the Market Growth

Ambulatory pump is a significant means of drug delivery in a wide range of medical situations. They play a vital role in supplying analgesics, chemotherapy, TPN infusion, and other infusions to patients in both hospitals and home care settings.

Also, ambulatory infusion pumps are portable devices intended for patients requiring continuous infusion therapy, allowing them to maintain mobility while receiving treatment. Patients may wear a pump in the pouch or attach it to their clothing so that they can move on the hospital floor while being treated. These infusion pumps are frequently used during patient transport and home infusion therapy.

• For instance, as per the data provided by Elite Biomedical Solutions, LLC in December 2021, ambulatory pumps are lightweight and provide mobility for patients needing continuous IV infusions.

In developed countries, the shift to site of care management of chronic diseases for the reduction of cost burdens associated with hospitals-based management is likely to increase demand for portable pumps in near future.

RESTRAINING FACTORS

Stringent Regulations for the Production of Pumps to Restrain Market Growth

Increasingly stringent regulations regarding the production and incorporation of pumps slow down the approval process for new products. This factor is anticipated to restrain the market growth.

Moreover, increasing product recalls due to product errors are restricting the market growth. Also, the U.S. FDA has made a statement regarding the infusion pump recall. According to the FDA, more than 50,000 units of the Model 4000 syringe pumps received product recall for correction. These infusion pumps were distributed from November 2010 to July 2023.

• In August 2019, for example, Fresenius Kabi recalled Vigilant Agilia drug library and Volumat MC Agilia infusion pump due errors to an infusion alarm, low priority keep vein open (KVO), and multiple errors associated with software.

Infusion Pump Market Segmentation Analysis

By Type Analysis

Insulin Pump Segment to Hold Leading Share of the Market Due to Growing Number of Diabetic Patients

Based on type, the market is segmented into volumetric pumps, syringe pumps, enteral feeding pumps, insulin pump, elastomeric pumps, implantable pump, and patient control analgesia (PCA) pumps. Globally the insulin pump segment dominated the global market. The segment is projected to continue its dominance by expanding at significantly high growth rate during the forecast period. This is attributable to growing number of type 1 diabetic patient population globally and introduction of promising technologies in insulin pump area. Growing applications of PCA pumps in pain management are likely to boost the global product demand in coming years. The insulin pump segment is forecast to represent 26.04% of total market share in 2026.

To know how our report can help streamline your business, Speak to Analyst

By Application Analysis

Diabetes Application Segment to Hold Lion’s Share Due to Increasing Prevalence of Diabetes around Globe

In terms of application, market segments include diabetes, oncology, pain management, and others. Among them, the diabetes segment held largest market share in the year 2023. The segment is estimated to grow at highest CAGR during the forecast period. This is primarily due to the rising prevalence of diabetes and increasing regulatory approvals for insulin pumps. The others segment is forecast to represent 45.88% of total market share in 2026.

• For instance, in September 2023, F. Hoffmann-La Roche Ltd. received U.S. FDA clearance for its lightweight, tubeless insulin pump, Accu-Chek Solo micropump. 

The oncology segment is expected to witness significant traction owing to the growing prevalence of various cancers and increasing new product launches in this area.

• For instance, as per the data provided by WHO in February 2024, around 20.0 million new cases of cancer and approximately 9.7 million deaths were reported in 2022.

Other application areas of this pump includes gastroenterology, hematology, pediatrics, and anesthesia, blood transfusion, and others.

By End User Analysis

Hospitals segment to Dominate Global Market Due to increasing Hospital Admissions Globally

Based on the end users, the market is segmented into hospitals, ambulatory care settings, specialty clinics and home care settings. Among them, the hospitals segment accounted for the largest share of 54.97% in the year 2026 due to hospitals’ high procuring power of costliest infusion devices, large patient pool visiting these facilities, and the readiness of trained staff to operate the pump. However, home care settings segment is expected to grow at the highest CAGR during the forecast period due to the growing adoption of ambulatory pumps and increasing preference for site of care management to reduce cost burden. Moreover, increasing government initiatives for the reduction of overall healthcare costs associated with prolonged hospitalization is likely to support the rising demand for infusion systems in the homecare setting.

REGIONAL ANALYSIS

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for a market size of USD 4.89 billion in 2025, positioning the region as the largest contributor to the global infusion pump market. Its strong market position is supported by high diagnosis and treatment rates for chronic conditions, particularly diabetes, along with widespread adoption of ambulatory and wearable infusion pumps across hospital and homecare settings. A well-defined regulatory framework and favorable reimbursement policies facilitate faster adoption of advanced devices, while continuous technological advancements in medical devices, including smart and connected pumps, are further strengthening regional demand. The U.S. market is valued at USD 4.79 billion by 2026.

Europe

Europe held the second-largest share of the global infusion pump market, supported by a robust public healthcare system and increasing burden of chronic diseases across the region. Regulatory oversight remains stringent, ensuring high safety and performance standards for infusion devices, which supports consistent product adoption. Significant healthcare expenditure by the European Commission and national health systems is anticipated to drive demand for infusion pumps, particularly in hospital and outpatient care, during the 2024–2032 period as healthcare providers focus on improving treatment accuracy and patient outcomes. The UK market is valued at USD 0.4 billion by 2026, while the Germany market is valued at USD 0.98 billion by 2026.

Asia Pacific

Asia Pacific is projected to register a comparatively higher CAGR during the forecast period, driven by rapid expansion of healthcare infrastructure and rising prevalence of chronic diseases such as diabetes and cancer. The region’s market position is strengthening as regulatory systems continue to mature, supporting wider approval and adoption of advanced infusion technologies. Increasing awareness of modern therapeutic options, coupled with expanding access to healthcare services, is accelerating demand across both urban and semi-urban healthcare facilities, making Asia Pacific a key growth engine for the global market. The Japan market is valued at USD 0.7 billion by 2026, the China market is valued at USD 0.92 billion by 2026, and the India market is valued at USD 0.31 billion by 2026.

Latin America

Latin America represents an emerging market for infusion pumps and is expected to witness accelerated growth over the forecast period. While the market remains in a relatively early stage of development, improving healthcare infrastructure and gradual regulatory strengthening are supporting increased device adoption. Demand is being driven by rising diagnosis rates of chronic diseases and growing interest from global manufacturers expanding their regional footprint to capture untapped opportunities.

To know how our report can help streamline your business, Speak to Analyst

List of Key Companies in Infusion Pump Market

Strong Geographic Presence of Key Players Owing to Strong Expansion strategies and Product Diversification

The market is characterized by presence of large number of major players offering various types of pumps in diverse application categories. The market is highly fragmented however, companies like Becton Dickinson, Baxter, and Medtronic, are successful to maintain dominating positions in their respective segment product categories. Expansion of product portfolio through organic as well as inorganic growth and strengthening of distribution channels across all the regions of the globe including emerging countries such as India, China, and Brazil are major winning imperatives to be noted. The regional players are making this market competitive by increasing pricing pressure. Other prominent players studied in the report include icumedical, B. Braun Melsungen AG.

LIST OF KEY COMPANIES PROFILED:

• Medtronic (Ireland)
• Becton Dickinson and Company (U.S.)
• Baxter (U.S.)
• Insulet Corporation (U.S.)
• ICU Medical, Inc. (U.S.)
• B. Braun Melsungen AG (Germany)
• Smiths Medical (Smiths Group plc.) (U.S.)
• Fresenius Kabi AG (Germany)
• Terumo Corporation (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

KEY INDUSTRY DEVELOPMENTS:

• August 2023- ICU Medical Inc. announced U.S. FDA approval for its Plum Duo infusion pump featuring LifeShield infusion safety software.
• November 2022- Medtronic introduced its Extended Infusion set, designed for insulin delivery with a wear duration of seven days.  
• April 2021- Medtronic has launched world’s first and only infusion set that can be used for up to seven days in select European countries. This set is responsible for delivering insulin from the pump into the human body. This new set is compatible with all MiniMed 600 and 700 series insulin pumps.
• August 2020- Mindray has launched new generation infusion system named as BeneFusion n Series. It offers deep insights into the safety of patient, interoperability and data management, operational simplicity which helps in setting new standards in infusion therapy.

REPORT COVERAGE

The market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation